Status:
COMPLETED
Chemoprophylaxis Plus Early Ambulation
Lead Sponsor:
Shen Lei
Conditions:
Pulmonary Embolism
Thoracic Surgery
Eligibility:
All Genders
14-80 years
Phase:
PHASE4
Brief Summary
Pulmonary embolism (PE) can be a devastating postoperative complication and the leading cause of mortality after thoracic surgery. PE together with deep venous thrombosis (DVT) is called venous thromb...
Detailed Description
Investigators enrolled 598 patients who were sent to thoracic postoperative intensive care unit (ICU) ward right after surgery from August 8 to September 12 of 2017 and those patients stayed in ICU fo...
Eligibility Criteria
Inclusion
- Lung surgical patients who were sent to thoracic postoperative intensive care unit (ICU) ward right after surgery and stayed in ICU for at least 24 hours.
Exclusion
- Cases received inferior vena filter and anti-coagulation treatment history.
Key Trial Info
Start Date :
August 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2017
Estimated Enrollment :
581 Patients enrolled
Trial Details
Trial ID
NCT03862755
Start Date
August 8 2017
End Date
November 11 2017
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200433